NCT01300871终止不适用
Alopecia Secondary to Endocrine Therapy in Postmenopausal Women With Breast Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Severity of Alopecia Tool (SALT)
研究概览
简要总结
This is a study to determine the prevalence and severity of alopecia (hair loss) experienced by postmenopausal breast cancer patients receiving endocrine therapy including Tamoxifen, Letrozole (Femara), Exemestane (Aromasin), or Anastrozole (Arimidex).
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 40 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Postmenopausal women
- •Diagnosed with hormone-receptor positive breast cancer
- •Commenced adjuvant endocrine therapy ≥ 3 months ago, specifically Tamoxifen, Anastrozole, Exemestane, and/or Letrozole
- •Good command of the English language
- •Under the care of a medical oncologist at Princess Margaret Hospital
排除标准
- •Previously received chemotherapy
- •Recurrent and/or metastatic disease
- •History of endocrine, dermatology, or immune system disorders known to alter hair growth (ie. Hypothyroidism and iron deficiency)
结局指标
主要结局
Severity of Alopecia Tool (SALT)
时间窗: 1 year
The proportion of postmenopausal breast cancer patients on endocrine therapy who experience grade S1 to S5 alopecia as defined by the Severity of Alopecia Tool (SALT).
次要结局
- Severity of Alopecia Tool (SALT)(1 year)
- Comparison of Tamoxifen, AI or Tamoxifen plus AI(1 year)
研究者
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
不适用
Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer PatientsBreast CarcinomaNCT05612100Mayo Clinic169
招募中
不适用
To study the association of Male pattern baldness and ObesityCTRI/2012/09/003032ESIC PGIMSR80
尚未招募
Unknown
A study of male pattern hair loss, its association with common skin diseases and bahavioural parameters( Aggression and Anxiety)CTRI/2024/05/066612nil
已完成
不适用
A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser TherapyAndrogenetic AlopeciaNCT01967277Capillus, LLC44
Unknown
不适用
Pharmacogenomic Study of Androgenetic AlopeciaAndrogenetic AlopeciaNCT01227031Taipei Medical University WanFang Hospital400